IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Press releases
IntegraGen Reports Revenue of €6.9 million for 2018 (+11%) and Cash Position of €4.0 million
-
Press releases
IntegraGen Announces Collaboration with Google Cloud to Offer Large Scale Genomic Analysis Tools for Clinicians and Medical Researchers
-
News
IntegraGen presents new data expanding application of miR-31 to stage III colon cancer during ESMO 2018